EATG » Scientific research

Scientific research

Targeting dormant HIV

Discovery of a novel, advanced technique to identify the rare cells where HIV hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for…

Study explores potency of antibodies to combat HIV infection

Rutgers' New Jersey Medical School is selected as test site for novel study Rutgers' New Jersey Medical School's Clinical Research Center (NJMS-CRC) is participating as a clinical trial site in…

ABIVAX completes the second milestone in CaReNa, a “Strategic Industrial Innovation Project” supported by Bpifrance

PARIS, September 13: ABIVAX, an innovative biotechnology company targeting the immune system to eliminate viral disease, reported that it has completed the second key milestone of the Strategic Industrial Innovation…

Aphios to develop HIV/AIDS cure using combination drugs in targeted ‘nanosomes’ nanoparticles

WOBURN, Mass., September 13--Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted ‘nanosomes’ nanoparticles with recent funding…

Scientists discover antibodies that target holes in HIV’s defenses

New findings could lead to new AIDS vaccine candidates LA JOLLA, CA – September 12, 2016 – A new study from scientists at The Scripps Research Institute (TSRI) shows that…

First accurate simulation of a virus invading a cell

For the first time, scientists know what happens to a virus’ shape when it invades a host cell, thanks to an experiment by researchers at Penn State College of Medicine…

Training human antibodies to protect against HIV

During HIV infection, the virus mutates too rapidly for the immune system to combat, but some people produce antibodies that can recognize the virus even two years after infection. With…

New mouse model technology could speed the search for an AIDS vaccine

Researchers at Boston Children's Hospital have developed a technology to quickly generate mouse models for testing and tweaking potential HIV vaccines. Such models could speed up the quest for the…

Researchers find other layers of immunity in TB/HIV co-infections

Tulane University researchers found some monkeys whose immune systems are depleted by the simian strain of HIV have a second line of defense against tuberculosis. The discovery could have significant…

Does on-demand PrEP really work?

This article from POZ.com discusses if on-demand dosing of PrEP, i.e. taking it before, in the days and after sexual intercourse(s), also known as intermittent dosing, provides sufficient protection against…